BioStock: Fluicell makes its mark in neuroscience field
Neurodegenerative diseases are a rapidly growing concern with an increasingly aging population. Decades of research have made it possible to generate neuronal cell cultures in a lab to study their behaviour in disease or injury models or for drug testing. However, these man-made cells lack the complexity of neural tissue to appropriately replicate natural behaviour inside the human body. Gel-free bioprinting has the capacity to address this issue, and Biopixar, Fluicell’s 3-D bioprinter, has shown that direct printing of neurons is possible, which is an important step to create better
Elkem has been awarded NOK 4.4 million in support from Enova to develop technology that has the potential to enable new green value chains based on unused hydrogen from the company's silicon production in Bremanger, Norway.Elkem has a surplus of hydrogen from the production of the silicon product Silgrain at the company's operations in Bremanger, Norway. The hydrogen is of good quality, and in collaboration with the independent research institute SINTEF the company is doing research to make better use of this resource. By drying and compressing the hydrogen, this can become a future
